Zotefoams plc
("Zotefoams" or "the Group")
Appointment of Joint Broker
08 October 2019 - Zotefoams, a world leader in cellular materials technology, today announces the appointment of Peel Hunt LLP to act as its joint broker alongside Investec Bank plc, with immediate effect.
-Ends-
Enquiries:
Zotefoams plc |
+44 (0) 208 664 1600 |
David Stirling, Group CEO |
|
Gary McGrath, Group CFO |
|
|
|
IFC Advisory |
+44 (0) 203 934 6630 |
Graham Herring Zach Cohen |
|
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.
www.zotefoams.com
AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc
MuCell® is a registered trademark of Trexel Inc.